Phase 1 single-ascending dose study of the safety and pharmacokinetics of 24 hour intravenous 5-HTP (EVX-301)

Clinical Trial Grant

Duke Scholars

Principal Investigator Shruti Mukund Raja Neurology, Neuromuscular Disease

Awarded By

EVECXIA Therapeutics

Start Date

April 5, 2020

End Date

September 3, 2020

Awarded By

EVECXIA Therapeutics

Start Date

April 5, 2020

End Date

September 3, 2020